CANN TREES Corp (Colorado)
Retail-Drug Stores and Proprietary Stores · OTC · SEC CIK 1477009 · Fiscal year ends 12/31
Financial factors as of 2024-06-30 (2024Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY-9.1%
TTM net income YoY54.0%
TTM EPS YoY58.3%
Revenue 3-yr CAGR70.8%
Net income 3-yr CAGR—
Margins
Gross margin40.2%
Operating margin-10.4%
Net margin-37.1%
FCF margin—
EBITDA margin-5.9%
Returns
ROE-2,861.9%
ROA-22.1%
ROIC (approx.)-7.8%
Asset turnover0.60x
Leverage & solvency
Liabilities / assets109.6%
Debt / equity—
Current ratio0.24x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.14x
Accruals ratio-18.9%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20232023-12-31 | FY20222022-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $18.14M | $13.44M |
| Cost of revenue | $11.56M | $8.58M |
| Gross profit | $6.57M | $4.87M |
| SG&A expense | $8.22M | $6.56M |
| Operating income | -$3.97M | -$3.17M |
| Interest expense | $1.76M | $983,181 |
| Pretax income | -$6.89M | -$9.28M |
| Income tax | $187,848 | $204,917 |
| Net income | -$7.08M | -$9.48M |
| EBITDA | -$3.10M | -$2.84M |
| EPS (basic) | -0.06 | -0.10 |
| EPS (diluted) | -0.06 | -0.10 |
| Weighted avg. shares (diluted) | 117.20M | 97.17M |
| Banking | ||
| Provision for credit losses | — | $6,280 |
| Balance sheet | ||
| Cash & equivalents | $969,676 | $2.58M |
| Receivables | $111,863 | $41,373 |
| Inventory | $860,918 | $2.07M |
| Current assets | $2.35M | $4.95M |
| PP&E, net | $1.40M | $1.95M |
| Goodwill | $15.88M | $18.38M |
| Intangibles | $1.64M | $2.54M |
| Total assets | $23.25M | $31.69M |
| Current liabilities | $7.37M | $6.14M |
| Short-term debt | $1.09M | $1.90M |
| Long-term debt | $14.01M | $15.90M |
| Total debt | $15.11M | $17.80M |
| Total liabilities | $23.10M | $25.29M |
| Shareholders' equity | $148,159 | $6.41M |
| Net debt | $14.14M | $15.22M |
| Shares outstanding | 108.75M | 118.66M |
| Cash flow statement | ||
| Operating cash flow | -$1.13M | -$2.05M |
| Capital expenditure | — | $61,611 |
| Free cash flow | — | -$2.11M |
| Investing cash flow | -$304,420 | -$1.95M |
| Financing cash flow | -$184,255 | $4.53M |
| Depreciation & amortization | $874,412 | $331,376 |
| Stock-based compensation | $69,071 | $188,330 |
Free plan shows the latest 2 periods; Pro shows all 13 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.